日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The CCL17-CCR4 Axis Is Critical for Mutant STAT6-Mediated Microenvironmental Remodeling and Therapeutic Resistance in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.

CCL17-CCR4轴对于突变STAT6介导的微环境重塑和复发/难治性弥漫性大B细胞淋巴瘤的治疗耐药性至关重要。

Abraham Madelyn J, Guilbert Cynthia, Gagnon Natascha, Gonçalves Christophe, Benoit Alexandre, Tran Kelly, Hiltebrand Owen, Rys Ryan N, Preston Samuel E J, Morin Ryan D, Miller Wilson H Jr, Johnson Nathalie A, Del Rincon Sonia V, Mann Koren K

A mixed inflammatory peripheral signature defines clinical outcomes in a phase II trial combining pembrolizumab with paclitaxel and carboplatin in melanoma

在黑色素瘤的II期临床试验中,帕博利珠单抗联合紫杉醇和卡铂治疗的临床结果与混合性炎症外周特征相关。

Lambert, Caroline; Jamal, Rahima; Thébault, Paméla; Cocolakis, Eftihia; Bélanger, Karl; Dionne, Jeanne; Cailhier, Jean-François; Le, Huy; Letendre, Caroline; Lepage, Stéphanie; Shechtman, Yelena; Lapointe, Réjean; Miller, Wilson H Jr

Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma

LOGIC 2 研究的简明语言摘要:恩考拉非尼、比美替尼联合第三种药物治疗 BRAF V600 突变型黑色素瘤患者

Dummer, Reinhard; Sandhu, Shahneen; Miller, Wilson H Jr; Butler, Marcus O; Taylor, Matthew H; Heinzerling, Lucie; Blank, Christian U; Couselo, Eva Muñoz; Burris, Howard A 3rd; Postow, Michael A; Chmielowski, Bartosz; Middleton, Mark R; Berking, Carola; Hassel, Jessica C; Gesierich, Anja Heike; Mauch, Cornelia; Kleha, Joseph F; Polli, Anna; Harney, Allison S; di Pietro, Alessandra; Ascierto, Paolo A

Single-Agent Divarasib in Patients With KRAS G12C-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study

Divarasib 单药治疗 KRAS G12C 阳性非小细胞肺癌患者:一项 I 期研究的长期随访

Sacher, Adrian G; Miller, Wilson H Jr; Patel, Manish R; Paz-Ares, Luis; Santoro, Armando; Ahn, Myung-Ju; Dziadziuszko, Rafal; Freres, Pierre; Luo, Jia; Bowyer, Samantha; Desai, Jayesh; Markman, Ben; De Miguel, Maria; Deva, Sanjeev; Falcon, Alejandro; Alonso, Guzman; Guedes, João Daniel; Kim, Se Hyun; Krebs, Matthew G; Laurie, Scott A; Massarelli, Erminia; Medina, Laura; Prenen, Hans; Amatu, Alessio; Van Dongen, Marloes; Choi, Yoonha; Hou, Xuefeng; Qi, Ting; Lin, Mark T; Koli, Kalpesh; Mayo, Mariah C; Yau, Kenneth K; Royer-Joo, Stephanie; Chang, Julie; Jun, Tomi; Dharia, Neekesh V; Schutzman, Jennifer L; Lorusso, Patricia

Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma

纵向基因组分析优化靶向治疗:BRAFV600突变转移性黑色素瘤患者的II期LOGIC 2试验结果

Dummer, Reinhard; Sandhu, Shahneen; Miller, Wilson H Jr; Butler, Marcus O; Taylor, Matthew H; Heinzerling, Lucie; Blank, Christian U; Muñoz-Couselo, Eva; Burris, Howard A 3rd; Postow, Michael A; Chmielowski, Bartosz; Middleton, Mark R; Berking, Carola; Hassel, Jessica C; Gesierich, Anja Heike; Mauch, Cornelia; Kleha, Joseph F; Polli, Anna; Harney, Allison S; di Pietro, Alessandra; Ascierto, Paolo A

Lack of phospho-eIF4E worsens experimental colitis by inhibiting Treg suppressive activity

磷酸化eIF4E的缺乏会通过抑制Treg细胞的抑制活性而加重实验性结肠炎。

Santinon, François; Papadopoulos, Theodoros; Berg, Meagan-Helen Henderson; McCallum, Paige; Abraham, Madelyn J; Gonçalves, Christophe; Gupta, Vrinda; Gagnon, Natascha; Wirasinghe, Noah; Chou, Hsiang; Esfahani, Khashayar; Bartish, Margarita; Miller, Wilson H Jr; Del Rincon, Sonia Victoria

Protocol for antibody optimization and panel design in high-dimensional multiplexed immunofluorescence imaging.

高维多重免疫荧光成像中抗体优化和面板设计的方案。

Gupta Vrinda, Abraham Madelyn J, Goncalves Christophe, Miller Wilson H Jr, Del Rincón Sonia V

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Divarasib联合西妥昔单抗治疗KRAS G12C阳性结直肠癌:一项1b期试验

Desai, Jayesh; Alonso, Guzman; Kim, Se Hyun; Cervantes, Andres; Karasic, Thomas; Medina, Laura; Shacham-Shmueli, Einat; Cosman, Rasha; Falcon, Alejandro; Gort, Eelke; Guren, Tormod; Massarelli, Erminia; Miller, Wilson H Jr; Paz-Ares, Luis; Prenen, Hans; Amatu, Alessio; Cremolini, Chiara; Kim, Tae Won; Moreno, Victor; Ou, Sai-Hong I; Passardi, Alessandro; Sacher, Adrian; Santoro, Armando; Stec, Rafal; Ulahannan, Susanna; Arbour, Kathryn; Lorusso, Patricia; Luo, Jia; Patel, Manish R; Choi, Yoonha; Shi, Zhen; Mandlekar, Sandhya; Lin, Mark T; Royer-Joo, Stephanie; Chang, Julie; Jun, Tomi; Dharia, Neekesh V; Schutzman, Jennifer L; Han, Sae-Won

MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma

MNK1/2抑制可限制KIT突变型黑色素瘤的致癌性和转移性

Zhan, Yao; Guo, Jun; Yang, William; Goncalves, Christophe; Rzymski, Tomasz; Dreas, Agnieszka; Żyłkiewicz, Eliza; Mikulski, Maciej; Brzózka, Krzysztof; Golas, Aniela; Kong, Yan; Ma, Meng; Huang, Fan; Huor, Bonnie; Guo, Qianyu; da Silva, Sabrina Daniela; Torres, Jose; Cai, Yutian; Topisirovic, Ivan; Su, Jie; Bijian, Krikor; Alaoui-Jamali, Moulay A; Huang, Sidong; Journe, Fabrice; Ghanem, Ghanem E; Miller, Wilson H Jr; Del Rincón, Sonia V

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses

抑制MNK1/2-eIF4E轴可损害黑色素瘤表型转换并增强抗肿瘤免疫反应。

Huang, Fan; Gonçalves, Christophe; Bartish, Margarita; Rémy-Sarrazin, Joelle; Issa, Mark E; Cordeiro, Brendan; Guo, Qianyu; Emond, Audrey; Attias, Mikhael; Yang, William; Plourde, Dany; Su, Jie; Gimeno, Marina Godoy; Zhan, Yao; Galán, Alba; Rzymski, Tomasz; Mazan, Milena; Masiejczyk, Magdalena; Faber, Jacek; Khoury, Elie; Benoit, Alexandre; Gagnon, Natascha; Dankort, David; Journe, Fabrice; Ghanem, Ghanem E; Krawczyk, Connie M; Saragovi, H Uri; Piccirillo, Ciriaco A; Sonenberg, Nahum; Topisirovic, Ivan; Rudd, Christopher E; Miller, Wilson H Jr; Del Rincón, Sonia V